Literature DB >> 30360714

Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies.

Aida Pitarch1,2, César Nombela1, Concha Gil1,2.   

Abstract

Invasive Candidiasis (IC) poses a major public health problem worldwide. Despite the introduction of new antifungal agents and changes in clinical practices, its morbidity and mortality rates and healthcare costs remain persistently high. This is mainly because of the serious underlying conditions of infected patients (critically ill or severely immunocompromised patients) and the difficulties encountered in early diagnosing this opportunistic mycosis and initiating prompt and appropriate antifungal therapy. In the light of this great clinical challenge, the past decades have witnessed the development of diverse early detection and therapeutic intervention strategies aimed at minimizing the clinical impact and economic burden of this healthcare-associated infection caused by Candida species. Here, we review the currently available methods for IC diagnosis. These encompass (i) gold standard methods (fungal culture and tissue histopathology), (ii) pathogen-derived biomarker detection tests (PCR, protein antigens, mannan, ß-D-glucan and D-arabinitol-based assays), (iii) host-derived biomarker detection tests (Candida albicans germ tube antibodies or CAGTA, anti-mannan antibodies, other infection-specific antibodies, procalcitonin, serum amyloid A, interleukin 17, interleukin 23 and transforming growth factor ß-based assays), (iv) clinical prediction algorithms (Candida score, Candida colonization index and other prediction rules), and (v) leading-edge molecular, proteomic and immunomic technologies (such as peptide nucleic acid-fluorescent in situ hybridization or PNA-FISH, T2 magnetic resonance or T2Candida assay, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or MALDI-TOF MS, among others). Their strengths, utility, limitations as well as combined use to assist in the diagnosis of this life-threatening and costly fungal infection (including candidemia and deepseated candidiasis) are also discussed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Candida score; Candidemia; Diagnosis; Invasive candidiasis; MALDI-TOF; PNA-FISH; T2 Candida; β-D-glucan.

Mesh:

Substances:

Year:  2018        PMID: 30360714     DOI: 10.2174/1568026618666181025093146

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  10 in total

1.  Longitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis.

Authors:  Stefanie Wunsch; Christoph Zurl; Heimo Strohmaier; Andreas Meinitzer; Jasmin Rabensteiner; Wilfried Posch; Cornelia Lass-Flörl; Oliver Cornely; Gudrun Pregartner; Elisabeth König; Gebhard Feierl; Martin Hoenigl; Juergen Prattes; Ines Zollner-Schwetz; Thomas Valentin; Robert Krause
Journal:  J Fungi (Basel)       Date:  2021-02-01

2.  Synergistic Antibiofilm Effects of Pseudolaric Acid A Combined with Fluconazole against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition.

Authors:  Bin Zhu; Zhen Li; Hongmei Yin; Jun Hu; Yingjun Xue; Guanyi Zhang; Xin Zheng; Weiqin Chen; Xiaobo Hu
Journal:  Microbiol Spectr       Date:  2022-03-17

3.  Biomarkers of fungal infection: Expert opinion on the current situation.

Authors:  E Bouza; B Almirante; J García Rodríguez; J Garnacho-Montero; M Salavert; P Muñoz; M Sanguinetti
Journal:  Rev Esp Quimioter       Date:  2019-11-14       Impact factor: 1.553

4.  Evaluation of a Novel Laboratory Candiduria Screening Protocol in the Intensive Care Unit.

Authors:  Zhengxin He; Chang Su; Yuwang Bi; Yan Cheng; Daxin Lei; Fukun Wang
Journal:  Infect Drug Resist       Date:  2021-02-10       Impact factor: 4.003

Review 5.  The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches.

Authors:  Zoe Freeman Weiss; Armando Leon; Sophia Koo
Journal:  J Fungi (Basel)       Date:  2021-02-09

6.  PCR-detectable Candida DNA exists a short period in the blood of systemic candidiasis murine model.

Authors:  Zheng-Xin He; Hui-Hai Zhao; Fu-Kun Wang
Journal:  Open Life Sci       Date:  2020-09-06       Impact factor: 0.938

Review 7.  Diagnosis and Treatment of Invasive Candidiasis.

Authors:  Natalia Barantsevich; Elena Barantsevich
Journal:  Antibiotics (Basel)       Date:  2022-05-26

8.  Mass Spectrometry-Based Proteomic and Immunoproteomic Analyses of the Candida albicans Hyphal Secretome Reveal Diagnostic Biomarker Candidates for Invasive Candidiasis.

Authors:  Catarina Vaz; Aida Pitarch; Emilia Gómez-Molero; Ahinara Amador-García; Michael Weig; Oliver Bader; Lucía Monteoliva; Concha Gil
Journal:  J Fungi (Basel)       Date:  2021-06-23

9.  Reinvestigation of Carbohydrate Specificity of EBCA-1 Monoclonal Antibody Used for the Detection of Candida Mannan.

Authors:  Vadim B Krylov; Arsenii S Solovev; Ilya A Puchkin; Dmitry V Yashunsky; Anna V Antonets; Olga Y Kutsevalova; Nikolay E Nifantiev
Journal:  J Fungi (Basel)       Date:  2021-06-24

10.  Expression and Purification along with Evaluation of Serological Response and Diagnostic Potential of Recombinant Sap2 Protein from C. parapsilosis for Use in Systemic Candidiasis.

Authors:  Manisha Shukla; Pankaj Chandley; Harsimran Kaur; Anup K Ghosh; Shivaprakash M Rudramurthy; Soma Rohatgi
Journal:  J Fungi (Basel)       Date:  2021-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.